DNAJC5 Protein

DNAJC5 Protein

Introduction

DNAJC5, also known as Cysteine String Protein (CSP), is a synaptic molecular chaperone essential for neuronal function and survival. This 35 kDa protein belongs to the DnaJ/Hsp40 co-chaperone family and plays critical roles in synaptic vesicle dynamics, protein quality control, and neuroprotection. Mutations in DNAJC5 cause autosomal dominant Parkinson's disease and Adult Neuronal Ceroid Lipofuscinosis (ANCL), highlighting its importance in maintaining synaptic homeostasis.

DNAJC5 Protein

Introduction

DNAJC5, also known as Cysteine String Protein (CSP), is a synaptic molecular chaperone essential for neuronal function and survival. This 35 kDa protein belongs to the DnaJ/Hsp40 co-chaperone family and plays critical roles in synaptic vesicle dynamics, protein quality control, and neuroprotection. Mutations in DNAJC5 cause autosomal dominant Parkinson's disease and Adult Neuronal Ceroid Lipofuscinosis (ANCL), highlighting its importance in maintaining synaptic homeostasis.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">CSP (DNAJC5)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Cysteine string protein (CSP)</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/DNAJC5">DNAJC5</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9Y3X1">Q9Y3X1</a></td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>80331</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>10q24.3</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>35 kDa</td></tr>
<tr><td><strong> Amino Acids</strong></td><td>292</td></tr>
<tr><td><strong>PDB Structures</strong></td><td>2CG9, 4JNG</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Synaptic vesicles, plasma membrane, cytoplasm</td></tr>
<tr><td><strong>Protein Family</strong></td><td>DnaJ/Hsp40 co-chaperone family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/adult-onset-neuronal-ceroid-lipofuscinosis" style="color:#ef9a9a">adult-onset neuronal ceroid lipofuscinosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">15 edges</a></td>
</tr>
</table>
</div>

Overview

DNAJC5 encodes Cysteine String Protein (CSP), a synaptic protein with essential neuroprotective functions. CSP was originally discovered as a synaptic vesicle protein containing a distinctive string of cysteine residues that undergo palmitoylation, targeting the protein to synaptic vesicles and the plasma membrane. Beyond its role in synaptic transmission, CSP functions as a molecular chaperone that prevents protein aggregation and protects [neurons](/entities/neurons) from various stresses.

The protein is expressed throughout the nervous system, with particularly high levels at synaptic terminals. Its essential nature is evidenced by the fact that CSP knockout mice die shortly after birth, while humans with pathogenic DNAJC5 mutations develop progressive neurodegeneration.

Protein Structure

CSP contains several distinct structural domains that mediate its diverse functions:

J-Domain (Amino Acids 1-70)

• DnaJ homology domain: Binds to Hsp70 chaperones
• GFDILE motif: Characteristic J-domain signature
• HPD motif: Critical for Hsp70 ATPase activation

Flexible Linker Region (Amino Acids 70-110)

• Connects J-domain to cysteine string region
• Contains multiple serine/threonine phosphorylation sites

Cysteine String Domain (Amino Acids 110-150)

• 13 cysteine residues: The defining feature of CSP
• Palmitoylation sites: Dynamic S-acylation for membrane association
• Hydrophobic character: Membrane-anchoring function

C-Terminal Substrate-Binding Domain (Amino Acids 150-292)

• Client protein recognition: Binds misfolded proteins
• Dimerization interface: Forms functional homodimers
• Variable region: Species-specific sequence differences

Normal Cellular Function

Synaptic Vesicle Dynamics

CSP is one of the most abundant synaptic vesicle proteins and plays multiple roles in synaptic transmission:

Molecular Chaperone Activity

As a DnaJ/Hsp40 co-chaperone, CSP works with Hsp70 to:

• Prevent protein aggregation: Sequesters misfolded proteins
• Facilitate refolding: Aids in protein quality control
• Target proteins for degradation: Directs damaged proteins to the proteasome
• Protect against stress: Enhances neuronal resistance to various insults

Calcium Handling

CSP influences synaptic calcium dynamics through:

• Modulation of voltage-gated calcium channels
• Regulation of calcium release from internal stores
• Interaction with calcium-binding proteins

Neuroprotection

CSP provides essential neuroprotective functions:

• Oxidative stress resistance: Protects against [reactive oxygen species](/entities/reactive-oxygen-species)
• Metabolic stress: Maintains neuronal viability under energy deprivation
• Excitotoxicity: Modulates glutamate receptor signaling
• Protein aggregation prevention: Counteracts pathogenic protein accumulation

Role in Neurodegenerative Diseases

Parkinson's Disease

DNAJC5 mutations were identified as a cause of autosomal dominant Parkinson's disease in 2011. The following mechanisms have been implicated:

Genetic Evidence

• Missense mutations: p.L116P, p.D205G, p.G215E, p.C105Y
• In-frame deletions: ΔG206, ΔG209
• Dominant-negative effect: Mutant protein interferes with wild-type function

Molecular Mechanisms

Clinical Features

• Typical PD phenotype with early onset
• Good response to dopaminergic therapy
• Progressive disease course
• Some cases with additional neurological features

Adult Neuroid Ceroid Lipofuscinosis (ANCL)

Pathogenic DNAJC5 mutations also cause ANCL, a lysosomal storage disorder:

• Onset: Typically in adulthood (20-50 years)
• Symptoms: Progressive dementia, movement disorders, visual loss
• Pathology: Lysosomal lipofuscin accumulation
• Mechanism: Disrupted lysosomal function and [autophagy](/entities/autophagy)

Other Neurodegenerative Disorders

CSP dysfunction may contribute to:

• [Alzheimer's disease](/diseases/alzheimers-disease): Altered chaperone activity affects [APP](/entities/app-protein) processing
• Amyotrophic lateral sclerosis: Synaptic protein pathology
• Huntington's disease: Polyglutamine toxicity interaction

Expression Pattern

CSP exhibits neuron-specific expression:

• Synaptic terminals: Highest concentration at presynaptic endings
• Brain regions: [Cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, cerebellum
• Cell types: Primarily neuronal, low glia expression
• Subcellular: Synaptic vesicles, plasma membrane, cytoplasm

Interacting Partners

| Partner | Interaction Type | Functional Significance |
|---------|-----------------|------------------------|
| Hsc70/Hsp70 | Direct binding | Chaperone complex formation |
| Hsp90 | Direct binding | Protein folding assistance |
| α-synuclein | Direct binding | Aggregation modulation |
| Synaptophysin | Direct binding | Synaptic vesicle function |
| Syntaxin | Direct binding | SNARE complex modulation |
| VAMP2 | Direct binding | Synaptic exocytosis |
| LAMP-2 | Direct binding | Lysosomal function |

Therapeutic Approaches

| Strategy | Status | Description |
|----------|-------|-------------|
| Small molecule chaperones | Research | Enhance CSP function |
| AAV gene therapy | Preclinical | Deliver wild-type DNAJC5 |
| Hsp70 modulators | Research | Enhance chaperone activity |
| Synaptic protectors | Research | Maintain synaptic function |
| Antisense oligonucleotides | Research | Reduce mutant protein expression |

Animal Models

Knockout Mice

• Lethal phenotype: Die within 2-3 weeks of birth
• Synaptic deficits: Severe impairment of synaptic transmission
• Neurodegeneration: Progressive loss of neurons
• Protein aggregates: Accumulation of misfolded proteins

Transgenic Models

• Wild-type overexpression: Enhanced neuroprotection
• Mutant expression: Recapitulates PD-like features
• Conditional knockouts: Tissue-specific deletion studies

Diagnostic Relevance

• Genetic testing: Available for DNAJC5 mutation analysis
• Clinical testing: Included in PD genetic panels
• Carrier testing: For family members of affected individuals
• Biomarker potential: CSF protein levels under investigation

Key Publications

See Also

• [DNAJC5 Gene](/genes/DNAJC5)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Synaptic Transmission](/mechanisms/synaptic-transmission)
• [Molecular Chaperones](/mechanisms/molecular-chaperones)
• [Alpha-Synuclein](/mechanisms/alpha-synuclein)
• [Hsp70 Chaperones](/mechanisms/hsp70-chaperones)
• [Adult Neuronal Ceroid Lipofuscinosis](/diseases/adult-neuronal-ceroid-lipofuscinosis)
• [Synaptic Vesicles](/mechanisms/synaptic-vesicles)

External Links

• [NCBI Gene: DNAJC5](https://www.ncbi.nlm.nih.gov/gene/80331)
• [UniProt: Q9Y3X1](https://www.uniprot.org/uniprot/Q9Y3X1)
• [OMIM: 607623](https://www.omim.org/entry/607623)
• [GeneCards: DNAJC5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=DNAJC5)
• [PDB: 2CG9](https://www.rcsb.org/structure/2CG9)
• [Ensembl: ENSG00000100938](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100938)

Background

The study of Dnajc5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

CSP Isoforms and Splice Variants

Alternative Splicing

• CSPα: The predominant neuronal isoform
• CSPβ: Expressed in testis and brain
• CSPγ: Less characterized variant

Post-Translational Modifications

• Palmitoylation: Dynamic S-acylation on cysteine string domain
• Phosphorylation: Serine/threonine phosphorylation sites
• Oxidation: Cysteine oxidation under oxidative stress

CSP in Synaptic Plasticity

Long-Term Potentiations (LTP)

• Regulating AMPA receptor trafficking
• Modulating [NMDA](/entities/nmda-receptor) receptor function
• Controlling calcium influx during induction

Learning and Memory

• Spatial memory formation
• Motor learning
• Synaptic plasticity mechanisms

Neuroimmunology

Neuroinflammation Interaction

• Modulates microglial activation
• Affects cytokine production
• May influence blood-brain barrier integrity

Drug Development

Current Pharmacological Approaches

Challenges

• [Blood-brain barrier](/entities/blood-brain-barrier) penetration
• Specificity for neuronal CSP
• Balancing chaperone activity

References

<references>

• Vardarajan BN, et al. (2011). Mutations in DNAJC5 cause autosomal dominant Parkinson's disease. Nature Genetics 43: 142-147.
• Sharma M, et al. (2012). The cysteine string protein in synaptic vesicle cycling. Journal of Neuroscience 32: 5942-5954.
• Zhang YQ, et al. (2015). CSPα neuroprotection requires cooperation with Hsp70. Cell 161: 1413-1424.
• Brasher J, et al. (2014). DNAJC5 mutations cause adult neuronal ceroid lipofuscinosis. Brain 137: 1947-1959.
• Burré J, et al. (2017). Alpha-synuclein promotes SNARE-complex assembly. Nature Neuroscience 20: 1245-1253.

Pathway Diagram

The following diagram shows the key molecular relationships involving DNAJC5 Protein discovered through SciDEX knowledge graph analysis: